missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Ephrin A2 Monoclonal Antibody (OTI4C3)
Mouse Monoclonal Antibody
Marca: Invitrogen™ MA525184
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
Ephrin A2 Monoclonal Antibody for Western Blot, ICC/IF, Flow
The Eph subfamily represents the largest group of receptor protein tyrosine kinases identified to date. While the biological activities of these receptors have yet to be determined, there is increasing evidence that they are involved in central nervous system function and in development. The Eph subfamily receptors of human origin (and their murine/avian homologs) include EphA1(Eph), EphA2 (Eck), EphA3 (Hek4), EphA4 (Hek8), EphA5 (Hek7), EphA6 (Hek12), EphA7 (Hek11/MDK1), EphA8 (Hek3), EphB1 (Hek6), EphB2 (Hek5), EphB3(Cek10, Hek2), EphB4 (Htk), EphB5 (Hek9) and EphB6 (Mep). Ligands for Eph receptors include ephrin-A4 (LERK-4) which binds EphA3 and EphB1. In addition, Ephrin-A2 (Elf-1) has been described as the ligand for EphA4, ephrin-A3 (Ehk1-L) as the ligand for EphA5 and ephrin-B2 (Htk-L) as the ligand for EphB4 (Htk).
Especificaciones
| Ephrin A2 | |
| Monoclonal | |
| 0.76 mg/mL | |
| PBS with 1% BSA, 50% glycerol and 0.02% sodium azide; pH 7.3 | |
| O43921 | |
| EFNA2 | |
| Full length human recombinant protein of EFNA2 produced in HEK293T cell. | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG1 |
| Flow Cytometry, Western Blot, Immunocytochemistry | |
| OTI4C3 | |
| Unconjugated | |
| EFNA2 | |
| CEK7L; CEK7-L; CEK7-ligand; EFNA2; Elf1; ELF-1; EPH related receptor tyrosine kinase ligand 6; eph-related receptor tyrosine kinase ligand 6; ephrin A2; ephrin A-2; ephrin A6; EphrinA2; ephrin-A2; Epl6; EPLG6; HEK7 ligand; HEK7-L; Lerk6; LERK-6 | |
| Mouse | |
| Affinity chromatography | |
| RUO | |
| 1943 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido